Conewago Pottsville

Conewago Pottsville is an addiction-treatment facility located in Pottsville, PA. The facility offers specific levels of care: Inpatient, MAT. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Conewago Pottsville

The care-level question matters because what a facility offers is what it can realistically treat well. The facility's documented care levels are The facility offers specific levels of care: Inpatient, MAT. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Conewago Pottsville's offerings match the clinical need.

Insurance and payment

On insurance specifically: Conewago Pottsville accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The facility also accepts TRICARE or military benefits. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adult women, Adult men, Seniors or older adults. Specialty programming varies substantially by facility — some facilities offer "dual diagnosis" as a marketing category but not a clinical differentiator. Ask for the specific clinical-team credentials and the actual hours of specialty-specific content per week.

Before you call

Before admission to Conewago Pottsville, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.